Highly rated in
Highly rated in
Check Dr. Baha M. Sibai's experience treating your condition:
About Dr. Baha M. Sibai

Baha Sibai is an Obstetrics and Gynecologist and a Neonatologist in Houston, Texas. Sibai has been practicing medicine for over 50 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Preeclampsia, Eclampsia, Intrauterine Growth Restriction, Hysterectomy, and Salpingo-Oophorectomy. He is licensed to treat patients in Ohio and Texas. Sibai is currently accepting new patients.

His clinical research consists of co-authoring 298 peer reviewed articles and participating in 6 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Baha M. Sibai it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Baha M. Sibai accepts the following insurance:

  •  Ambetter
  •  UnitedHealthcare
  •  Community Health
6410 Fannin St, Suite 600, Houston, TX 77030
Background & Education
Graduate Institution
Other, 1973
Obstetrics and Gynecology
Obstetrics & Gynecology in OH
Hospital Affiliations
Memorial Hermann - Texas Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Observational Study of Hepatitis C Virus in Pregnancy
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus (TEAM LGA Trial)
A Pragmatic Multicenter Randomized Clinical Trial (RCT) of Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project
Induction in Nulliparous Women at 39 Weeks to Prevent Adverse Outcomes: A Randomized Controlled Trial
Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women: A Randomized Controlled Trial (GROW Trial)
View 5 Less Clinical Trials -

297 Total Publications

Is conservative management of placenta accreta spectrum disorders practical in the United States?

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors